Novavax Inc (NVAX)

Industry Biotechnology


This stock can be held in an Investment ISA and an Investment Account
Sell

$6.90

Buy

$6.91

arrow-up$0.95 (+15.97%)

Prices updated at 08 May 2025, 15:05 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.
$7.50 - $6.48
$23.86 - $4.43
-
983.15m
-
-
19,649,273
-
8,350,096.94
2.90
161.94m
US6700024010
-1.23
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.